COVVI
COVVI designs and distributes the COVVI hand, an advanced bionic prosthetic targeting amputees and limb-different individuals. The Leeds, UK-based private company serves individual patients and healthcare providers within the rapidly growing intelligent bionic prosthesis market.
- Company typePrivate
- Founded2017
- HeadquartersLeeds, United Kingdom
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What COVVI does
COVVI is a private UK-based company founded in 2017 and headquartered in Leeds, specializing in the design and distribution of the COVVI hand, an advanced bionic prosthetic. The company serves amputees and limb-different individuals as its primary user base, with a secondary channel through healthcare providers and rehabilitation centers that distribute bionic prosthetics to patients requiring limb replacement. Use cases span upper and lower extremity prosthetics, including myoelectric and microprocessor-controlled devices, addressing restoration of limb function, improved mobility, and enhanced quality of life for individuals with limb loss due to trauma, disease, or congenital conditions.
The COVVI hand is positioned within the intelligent bionic prosthesis segment, where third-party sources cite AI-integrated prosthetic technologies as a key technological driver enabling more intuitive motor control and better user outcomes. The company emphasizes advanced bionic prosthetic solutions providing improved motor control, enhanced dexterity, and better integration with the human body compared to traditional prosthetic options. The upper limbs segment is specifically projected to exhibit substantial growth due to the complexity of restoring fine motor skills, which aligns with COVVI's hand-focused product strategy.
COVVI operates with a lean team of 11-50 employees in a market environment characterized by rapid expansion — the global intelligent bionic prosthesis market is projected to grow from $891 million (2025) to over $7.5 billion (2030), with adjacent markets (AI-powered prosthetics at 15.9% CAGR, robotic prosthetics at 9.4% CAGR, and broader artificial limbs at 5.60% CAGR) all showing strong forward momentum. The company operates in a segment challenged by high device costs and limited insurance reimbursement. No publicly disclosed pricing, distribution channels, revenue figures, funding rounds, management team details, patents, certifications, or partnerships are available for COVVI; the company website returns only a verification/loading page with no substantive content, and all available signals derive from third-party market analysis rather than first-party company disclosures.
COVVI firmographics
Firmographics- Name
- COVVI
- Website
- https://covvi.com
- Company type
- Private
- Founded year
- 2017
- Headcount range
- 11–50 employees
- Short description
- COVVI designs and distributes the COVVI hand, an advanced bionic prosthetic targeting amputees and limb-different individuals. The Leeds, UK-based private company serves individual patients and healthcare providers within the rapidly growing intelligent bionic prosthesis market.
- Ownership category
- akta.pro rank
COVVI industry classification
Industry- Product category
- Bionic Prosthetics
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems) (HLAHAEAH)
- akta.pro secondary industries
- Prosthetic Components & Rehabilitation Accessories (Liners, Feet, Knees, Sockets) (HLAHAMAD), Prosthetics/Orthotics Rehab & Amputee Rehabilitation (HSADAIAN)
Keywords
Where COVVI is headquartered
LocationHeadquarters
- HQ city
- Leeds
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
COVVI business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
COVVI product offering
Product offeringCore offering
COVVI designs and distributes the COVVI hand, a bionic prosthetic hand intended for amputees and limb-different individuals. The company operates in the upper-limb prosthetics segment of the intelligent bionic prosthesis and robotic prosthetics market, delivering advanced electromechanical prosthetic devices that aim to restore fine motor function.
Differentiator
Problem solved
Functional benefit
Products and services
- COVVI Hand
Companies that use COVVI
Customer profileSegments2 records
Ideal customer profiles2 records
COVVI technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
COVVI partnerships and signals
Strategic signalScale indicators4 records
Recent moves1 record
Expansion highlights1 record
COVVI competitors and assessment
Company assessmentDirect peers
- Steeper Group: Leeds-headquartered prosthetics manufacturer with a heritage upper-limb product line including the bebionic-equivalent Steeper hand. Particularly relevant as a fellow Leeds-based prosthetics peer competing for UK clinics.
- Psyonic: US-based maker of the Ability Hand, a bionic prosthetic hand with sensor-enabled touch feedback. Direct competitor in the AI/sensor-driven multi-grip hand space targeting upper-limb amputees.
- Open Bionics: Bristol-based developer of multi-grip bionic arms including the Hero Arm. The closest direct peer to COVVI given comparable product form factor (3D-printed multi-articulating hand), UK origin, and upper-limb amputee target market.
- TASKA Prosthetics: New Zealand-based maker of the TASKA multi-articulating waterproof prosthetic hand. Direct competitor in the bionic hand category with a similar feature focus on dexterity and ruggedization.
- Mobius Bionics: US company commercializing the LUKE/DEKA arm, an advanced multi-articulating prosthetic upper limb. Comparable AI-driven bionic upper-limb technology targeting similar patient populations.
- Touch Bionics (now part of Ottobock): Developed the i-LIMB multi-articulating prosthetic hand, the archetype product for COVVI's category. Now integrated into Ottobock but historically a direct competitor in bionic upper-limb prosthetics.
- Vincent Systems: German manufacturer of the Michelangelo and newer Evolution bionic hands. Direct competitor in the same multi-articulating upper-limb category with established European prosthetist distribution.
Broad incumbents
- Ottobock: Global prosthetics market leader offering the bebionic and Michelangelo myoelectric hands alongside a full lower-limb and orthopedic portfolio. Competes with COVVI in upper-limb myoelectric systems but at vastly greater scale and distribution.
- Össur: Global prosthetics and orthotics major with a broad upper- and lower-limb portfolio including bionic solutions. Competes with COVVI across the prosthetics channel but as a diversified incumbent rather than a hand specialist.
Emerging players
- BrainCo: US/China-based neurotechnology company producing the BrainRobotics bionic hand. Comparable AI/EMG-controlled upper-limb prosthetic emerging from a tech rather than traditional medical-device background.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
COVVI social profiles
Digital presenceCOVVI financial estimates
Financial estimateRevenue estimate
Valuation estimate
COVVI leadership team
Management profileNumber of profiles
COVVI funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
COVVI M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about COVVI
What does COVVI do?
COVVI designs and distributes the COVVI hand, a bionic prosthetic hand intended for amputees and limb-different individuals. The company operates in the upper-limb prosthetics segment of the intelligent bionic prosthesis and robotic prosthetics market, delivering advanced electromechanical prosthetic devices that aim to restore fine motor function.
When was COVVI founded?
COVVI was founded in 2017. It employs 11 to 50 people.
Where is COVVI based?
COVVI is headquartered in Leeds, United Kingdom, in the Europe region.
Who are COVVI's main competitors?
Direct peers on record are Steeper Group, Psyonic, Open Bionics, TASKA Prosthetics, Mobius Bionics, Touch Bionics (now part of Ottobock) and Vincent Systems. Broad incumbents are Ottobock and Össur. BrainCo is listed as an emerging player.
Does COVVI have an API?
No public API is recorded for COVVI.
What industry is COVVI in?
COVVI's product category is Bionic Prosthetics. Its primary akta.pro industry code is HLAHAEAH, Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems), with a secondary code of HLAHAMAD, Prosthetic Components & Rehabilitation Accessories (Liners, Feet, Knees, Sockets). Its NAICS code is 339113 and its SIC code is 3842.